Jw. Clark et al., METABOLISM AND BIOLOGICAL-ACTIVITY OF 1,25(OH)2D2 AND ITS METABOLITESIN A CHRONIC MYELOGENOUS LEUKEMIA-CELL LINE, RWLEU-4, Bioorganic & medicinal chemistry letters, 3(9), 1993, pp. 1873-1878
We previously described the metabolism of 1,25(OH)2D2 into various sid
e chain hydroxylated metabolites formed as a result of C-24, C-26 and
C-28 hydroxylations in rat kidney24. We now demonstrate C-24 hydroxyla
tion of 1,25(OH)2D2 in human leukemic cells and also present evidence
to show that C-24 and C-26 hydroxylations either alone or in combinati
on do not significantly alter the effect of 1,25(OH)2D2 on these cells
, while C-28 hydroxylation reduces its activity.